In some embodiments, the otic formulation or composition comprises between about 0.1% to about 40% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof
In practice, it is a chemically sensitive process that can influence experimental outcomes if not properly understood
Currently, there is no specific treatment for PVL, but many studies try to find specific agents to attenuate white matter damage by preventing cell death of pre-oligodendrocytes
Browse all Hormones & Fertility education Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims